Does anyone see this going closer to the 10c mark? Their financials have been fairly good compared with other Bio-techs with small caps and this is a pretty significant patent. It's downward shareprice trend in 2008 seems to have abated and looks like its got a solid foundation financially and IP wise.
there is a pattern here, page-5
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)